Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Topsun Puts Cold Medicine On The Market Again

This article was originally published in PharmAsia News

Executive Summary

Topsun Science and Technology has confirmed that "Black and White," its popular OTC cough and cold medicine, is back on the market. Bayer signed an agreement to acquire the drug in 2006, but the one-year contract, pending authorities' approval, had since expired. According to a Topsun official, price was a key factor in the re-negotiation due to the rising yuan against the dollar; the firm will lose out almost 100 million yuan if it abides by the original terms. China Resources and other corporations have expressed interest in acquiring Black and White. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068062

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel